Eloxx Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results and Provides Business Update

Go back to Eloxx Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results and Provides Business Update

Eloxx Pharmaceuticals (ELOX) Reports Q1 Loss of $0.31/Share

May 10, 2018 4:30 PM EDT

Eloxx Pharmaceuticals (NASDAQ: ELOX) reported Q1 EPS of ($0.31), versus ($0.73) reported last year.

For earnings history and earnings-related data on Eloxx Pharmaceuticals (ELOX) click here.

... More